STAAR Surgical Company
STAA · NASDAQ
12/27/2024 | 12/29/2023 | 12/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $313,901 | $322,415 | $284,391 | $230,472 |
| % Growth | -2.6% | 13.4% | 23.4% | – |
| Cost of Goods Sold | $74,319 | $69,764 | $61,008 | $51,835 |
| Gross Profit | $239,582 | $252,651 | $223,383 | $178,637 |
| % Margin | 76.3% | 78.4% | 78.5% | 77.5% |
| R&D Expenses | $53,973 | $44,401 | $35,983 | $33,862 |
| G&A Expenses | $89,898 | $72,319 | $54,742 | $44,142 |
| SG&A Expenses | $198,220 | $180,153 | $143,598 | $111,436 |
| Sales & Mktg Exp. | $108,322 | $107,834 | $88,856 | $67,294 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $252,193 | $224,554 | $179,581 | $145,298 |
| Operating Income | -$12,611 | $28,097 | $43,802 | $33,339 |
| % Margin | -4% | 8.7% | 15.4% | 14.5% |
| Other Income/Exp. Net | $3,559 | $5,599 | $1,750 | -$2,035 |
| Pre-Tax Income | -$9,052 | $33,696 | $45,552 | $31,304 |
| Tax Expense | $11,156 | $12,349 | $5,887 | $3,793 |
| Net Income | -$20,208 | $21,347 | $39,665 | $27,511 |
| % Margin | -6.4% | 6.6% | 13.9% | 11.9% |
| EPS | -0.41 | 0.44 | 0.83 | 0.52 |
| % Growth | -193.2% | -47% | 59.6% | – |
| EPS Diluted | -0.41 | 0.43 | 0.8 | 0.5 |
| Weighted Avg Shares Out | 49,125 | 48,523 | 47,987 | 47,210 |
| Weighted Avg Shares Out Dil | 49,125 | 49,427 | 49,380 | 49,456 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5,911 | $6,986 | $2,448 | – |
| Interest Expense | $0 | $0 | $0 | $38 |
| Depreciation & Amortization | $6,891 | $5,124 | $4,509 | $3,642 |
| EBITDA | -$5,720 | $33,221 | $48,311 | $36,981 |
| % Margin | -1.8% | 10.3% | 17% | 16% |